Literature DB >> 21122624

HDL as a treatment target.

W Virgil Brown1, H Bryan Brewer, Daniel J Rader, Ernst J Schaefer.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 21122624     DOI： 10.1016/j.jacl.2009.12.005

Source DB:  PubMed          Journal:  J Clin Lipidol        ISSN： 1876-4789            Impact factor:   4.766


× No keyword cloud information.
  3 in total

Review 1.  High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

2.  P2Y13 receptor regulates HDL metabolism and atherosclerosis in vivo.

Authors:  Marine Goffinet; Claudine Tardy; Nadia Boubekeur; Guy Cholez; Alice Bluteau; Daniela C Oniciu; Narendra D Lalwani; Jean-Louis H Dasseux; Ronald Barbaras; Rudi Baron
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

3.  HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation.

Authors:  Claudine Tardy; Marine Goffinet; Nadia Boubekeur; Guy Cholez; Rose Ackermann; Gavin Sy; Constance Keyserling; Narendra Lalwani; John F Paolini; Jean-Louis Dasseux; Ronald Barbaras; Rudi Baron
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.